What is the equity of Cochlear this year?
Cochlear has equity of 1.84 B AUD this year.
Cochlear Equity 2024
Cochlear Equity
1.84 B AUD
Ticker
COH.AX
ISIN
AU000000COH5
WKN
898321
In 2024, Cochlear's equity was 1.84 B AUD, a 9.18% increase from the 1.69 B AUD equity in the previous year.
Cochlear Aktienanalyse
What does Cochlear do?
Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Cochlear's Equity
Cochlear's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Cochlear's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Cochlear's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Cochlear's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Cochlear’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Cochlear stock
What was the equity of Cochlear compared to the previous year?
The equity of Cochlear has increased/decreased by 9.18% increased compared to the previous year.
What impact does a high equity have on investors of Cochlear?
A high equity is advantageous for investors of Cochlear as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Cochlear?
A low equity can be a risk for investors of Cochlear, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Cochlear affect the company?
An increase in equity of Cochlear can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Cochlear affect the company?
A reduction in equity of Cochlear can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Cochlear?
Some factors that can affect the equity of Cochlear include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Cochlear so important for investors?
The equity of Cochlear is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Cochlear take to change the equity?
To change equity, Cochlear can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Cochlear pay?
Over the past 12 months, Cochlear paid a dividend of 5.42 AUD . This corresponds to a dividend yield of about 1.85 %. For the coming 12 months, Cochlear is expected to pay a dividend of 5.68 AUD.
What is the dividend yield of Cochlear?
The current dividend yield of Cochlear is 1.85 %.
When does Cochlear pay dividends?
Cochlear pays a quarterly dividend. This is distributed in the months of April, October, April, October.
How secure is the dividend of Cochlear?
Cochlear paid dividends every year for the past 26 years.
What is the dividend of Cochlear?
For the upcoming 12 months, dividends amounting to 5.68 AUD are expected. This corresponds to a dividend yield of 1.94 %.
In which sector is Cochlear located?
Cochlear is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cochlear kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cochlear from 10/10/2024 amounting to 2.82 AUD, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.
When did Cochlear pay the last dividend?
The last dividend was paid out on 10/10/2024.
What was the dividend of Cochlear in the year 2023?
In the year 2023, Cochlear distributed 4.058 AUD as dividends.
In which currency does Cochlear pay out the dividend?
The dividends of Cochlear are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cochlear
Our stock analysis for Cochlear Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cochlear Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
